Pilatus Biosciences Inc., a biopharmaceutical company pioneering metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, announced the issuance of its foundational patent in Europe and Australia titled “Methods for Modulating Regulatory T Cells and Inhibiting Tumor Growth.” This milestone marks…
Nurea, a leader in AI-driven medical imaging innovation, has announced that its PRAEVAorta®2 software has received FDA 510(k) clearance, paving the way for its introduction into the U.S. healthcare market. The clearance marks a pivotal step in transforming the way…
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced the appointment of Giovanni Galliano as General Manager for Italy. This appointment marks Avanzanite’s seventh executive leadership hire in 2025, reinforcing its vision…
eClinical Solutions LLC, a global leader in digital clinical software and data management services, announced two significant achievements underscoring its commitment to advancing data science innovation. At the 2025 Society for Clinical Data Management (SCDM) Annual Conference, the company’s elluminate…
Celerion, a global leader in early clinical research, announced today that it has received full reaccreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for a period of five years. The Council on Accreditation of AAHRPP…
Perceptive Imaging, a global leader in clinical trial imaging solutions for the clinical research community, announced the appointment of Doug Fulling as Chief Executive Officer, succeeding David Herron, who led the company since 2022. Fulling officially assumed his new role…
Calira, formerly known as Clustermarket, has announced a major rebrand and the appointment of Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), as a non-executive director and investor. The move underscores Calira’s strategy to strengthen its position…
HAP International announced today that, following a successful technical assessment of its TRACE ID program by U.S. Customs and Border Protection (CBP), both organizations are moving toward a formal Memorandum of Agreement (MOA). This milestone underscores CBP’s commitment to adopting…
Altoida, Inc., a trailblazer in AI- and augmented reality (AR)-based digital diagnostics for neurological conditions, has announced the appointment of three globally recognized experts to its Clinical and Scientific Advisory Board. The new members — Dr. Mona Flores, former Global…
Masimo (NASDAQ: MASI) announced compelling new findings from an exploratory analysis of its Investigation of Skin Pigmentation Effect on Performance of Pulse Oximetry (INSPIRE) feasibility study, published in CHEST Critical Care. Led by Dr. Andrew Goodwin and colleagues at the…